CVS Health now offering COVID-19 vaccines in 29 states (2024)

Retail expansion follows successful vaccination effort at long-term care facilities

WOONSOCKET, R.I. — CVS Health (NYSE: CVS) has nearly doubled the number of states where select CVS Pharmacy locations are offering COVID-19 vaccines to eligible populations through the Federal Retail Pharmacy Program (FRPP). The company is now administering vaccines in nearly 1,200 stores across 29 states and Puerto Rico (states and jurisdictions activated within the past week in bold):

Alabama, Arizona, California, Colorado, Connecticut, Florida, Hawaii, Illinois, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Missouri, Montana, North Carolina, North Dakota, Nevada, New Jersey, New York (now including New York City), Ohio, Oklahoma, Pennsylvania (now including Philadelphia), Puerto Rico, Rhode Island, South Carolina, Texas, Utah, Vermont, and Virginia.

"We're increasing the number of active stores and expanding to additional states as fast as supply allows, with the capacity to administer 20 25 million shots per month," said Karen S. Lynch, President and Chief Executive Officer, CVS Health. "We're also focused on priority populations, including vulnerable communities disproportionately impacted by the pandemic as well as teachers and school support staff."

On March 2 the Biden Administration announced that for the month of March, FRPP participants would prioritize vaccinating pre-K through 12 educators and staff and child care workers. From March 3 to March 10, this population accounted for more than 30 percent of COVID-19 vaccine appointments at CVS Pharmacy locations.

Appointments in the newly activated states and jurisdictions will start to become available for booking on Saturday, March 13. Vaccines in a retail setting are offered on an appointment-only basis via CVS.com or through the CVS Pharmacy app, and those without online access can contact customer service: 800-746-7287.

Long-term care vaccination effort a success

Since CVS Health began administering COVID-19 vaccine doses to residents and staff at over 40,000 long-term care facilities across the country in late December, there has been a dramatic drop in COVID-19 cases and deaths. In fact, according to Centers for Disease Control and Prevention and Centers for Medicare & Medicaid Services data, between December 20 and February 21 there has been a 94 percent decrease in COVID-19 cases, and an 84 percent decrease in COVID-19 deaths.

Per the company's publicly available data, CVS Pharmacy teams have completed second doses at all skilled nursing facilities, and third and final visits are 90 percent complete. Second doses at assisted living and other facilities are 91 percent complete, with more than half of third and final visits complete.Excludes facilities that 1) requested a later date due to a COVID-19 outbreak or other reason, 2) were rescheduled due to lack of responsiveness, or 3) requested to be added to the program after the start date or did not meet original program criteria regarding distance from CVS Pharmacy locations, but CVS Health has opted to support. CVS Health has administered nearly 4.5 million COVID-19 vaccine doses through the Pharmacy Partnership for Long-Term Care Program.

Multimedia assets, including b-roll and still photography from long-term care facility and in-store COVID-19 vaccinations, are available here. More information on steps CVS Health has taken to address the pandemic is available at the company's frequently updated COVID-19 resource center.

About CVS Health

CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable and simply better. Learn more about how we're transforming health at www.cvshealth.com.

Cautionary Statement Concerning Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to risks and uncertainties described in our Securities and Exchange Commission ("SEC") filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward Looking Statements" in our most recently filed Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2020. You are cautioned not to place undue reliance on CVS Health's forward looking statements. CVS Health's forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.

Media contact

T.J. Crawford
212-457-0583
crawfordt2@aetna.com

CVS Health now offering COVID-19 vaccines in 29 states (2024)

FAQs

CVS Health now offering COVID-19 vaccines in 29 states? ›

WOONSOCKET, R.I. — CVS Health (NYSE: CVS) has nearly doubled the number of states where select CVS Pharmacy locations are offering COVID-19 vaccines to eligible populations through the Federal Retail Pharmacy Program (FRPP).

What is the most current COVID vaccine? ›

COVID-19 vaccines currently recommended for use in the United States:
  • Updated Pfizer-BioNTech.
  • Updated Moderna.
  • Updated Novavax.
May 14, 2024

Is Moderna or Pfizer better? ›

Pfizer: Is There a “Best” mRNA Vaccine? Both of the mRNA vaccines available in the US are highly effective against severe COVID-19, but recent studies suggest that Moderna's elicits a stronger immune response and might be better at preventing breakthrough infections.

Is Novavax still available in the US? ›

The previous Novavax vaccine is no longer authorized in the U.S.

What are the side effects of the Covishield vaccine? ›

Get medical attention immediately if from a few days following vaccination you get any of the following symptoms:
  • experience a severe or persistent headache, blurred vision, confusion or seizures (fits)
  • develop shortness of breath, chest pain, leg swelling, leg pain or persistent abdominal pain.

When did the latest COVID vaccine become available? ›

Adults 65 years or older should receive one additional dose of 2023-2024 vaccine at least 4 months following their last dose. (See information below for persons who have recently had a COVID-19 infection). The 2023-2024 vaccine has been available since September 2023.

Is the COVID vaccine no longer authorized? ›

As part of today's actions, the bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.

Is the newest COVID vaccine safe? ›

How safe is the updated COVID vaccine? COVID vaccines are safe and effective, according to the CDC. The safety of COVID vaccines has been rigorously monitored and evaluated since their emergency use authorization (EUA) in December 2020.

Is Moderna or Pfizer booster better for seniors? ›

A booster shot with the Moderna vaccine offered older people better protection against COVID-19 if they had previously taken Pfizer jabs, researchers at the National Centre for Infectious Diseases (NCID) have found.

How long does the COVID vaccine last? ›

How long does the COVID vaccine last? Studies suggest COVID vaccines are most effective in the first few months following your shot. That's why when health experts recommend boosters or updated doses, they're usually given three to four months after your last COVID shot.

Is there a new COVID variant in 2024? ›

An additional rapidly emerging variant, KP.3, is believed to have similar virological and epidemiological characteristics to KP.2. A third emerging variant, LB.1, is also a "FLiRT" variant. Its rapid increase since early June 2024 indicates that it may overtake KP.3 as the dominant variant in the future.

Why is Novavax better than mRNA? ›

Compared with mRNA vaccines, the Novavax booster seems to have a lower risk of causing myocarditis or pericarditis—heart conditions that occasionally occur, especially in young men—although it does not have zero risk.

What is the new COVID variant? ›

LB.1 is the latest COVID-19 subvariant to make headlines as it circulates in the United States. The highly contagious strain, which emerged shortly after the "FLiRT" variants, including KP.3 and KP.2, is causing an increasing proportion of infections.

How long does a vaccine stay in your body? ›

How long do spike proteins last in the body? The Infectious Disease Society of America (IDSA) estimates that the spike proteins that were generated by COVID-19 vaccines last up to a few weeks, like other proteins made by the body.

Who should not get the COVID-19 vaccine? ›

People should not get a protein subunit COVID-19 vaccine if they: Are younger than 12 years. Have had a severe allergic reaction (e.g., anaphylaxis) after a previous dose or to an ingredient of Novavax vaccine.

Which vaccine is best for COVID? ›

The CDC says there's a preference for the mRNA (Pfizer and Moderna) COVID-19 vaccines over the Novavax or Johnson & Johnson vaccines. This is based on data from the Advisory Committee on Immunization Practices (ACIP).

What are the top 3 vaccines for COVID? ›

The CDC says there's a preference for the mRNA (Pfizer and Moderna) COVID-19 vaccines over the Novavax or Johnson & Johnson vaccines.

What are the three main COVID vaccines? ›

The main types of COVID-19 vaccines currently available in the U.S. or being studied include:
  • Messenger RNA (mRNA) vaccine. This type of vaccine gives your cells instructions for how to make the S protein found on the surface of the COVID-19 virus. ...
  • Vector vaccine. ...
  • Protein subunit vaccine.

What are the new types of Covid-19 vaccines? ›

The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) approved the updated vaccines by Pfizer-BioNTech and Moderna for everyone 6 months and older, and authorized an updated Novavax vaccine for those 12 and older in the fall of 2023.

Top Articles
Latest Posts
Article information

Author: Terrell Hackett

Last Updated:

Views: 6498

Rating: 4.1 / 5 (52 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Terrell Hackett

Birthday: 1992-03-17

Address: Suite 453 459 Gibson Squares, East Adriane, AK 71925-5692

Phone: +21811810803470

Job: Chief Representative

Hobby: Board games, Rock climbing, Ghost hunting, Origami, Kabaddi, Mushroom hunting, Gaming

Introduction: My name is Terrell Hackett, I am a gleaming, brainy, courageous, helpful, healthy, cooperative, graceful person who loves writing and wants to share my knowledge and understanding with you.